Back to search

France· FR:66123498

RABEPRAZOLE ARROW GENERIQUES 20 mg, comprimé gastro-résistant

A rabeprazole product containing rabéprazole sodique, registered in France by ARROW GENERIQUES, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC A02BC04

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedRABEPRAZOLE ARROW GENERIQUES 20 mg, c…ATCA02BC04REGISTER NO.FR:66123498PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Rabeprazole is registered in 17 of 19 countries.

Countries holding a registration under ATC A02BC04 (rabeprazole), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose

Rabeprazole · ATC A02BC04

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rabeprazole costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.13 in France to $0.85 in Switzerland — a ×6.4 gap.

  • France: $0.13 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Rabeprazole · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.85
  • ES Spain$0.50
  • IT Italy$0.24
  • FR France$0.13
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
RABÉPRAZOLE SODIQUE
Manufacturer
ARROW GENERIQUES
Country
France (FR)
ATC code
A02BC04
ATC class
Rabeprazole
Defined daily dose
10 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400921849844
    plaquette(s) formée(s) à froid aluminium de 14 comprimé(s)
    EUR 1.89
  • cip13
    3400921850215
    plaquette(s) formée(s) à froid aluminium de 28 comprimé(s)
    EUR 3.43

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

592 interactions on record for rabeprazole.

Graded by severity as the source publishes them — 22 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Rabeprazole · interactions on record

592 records

  • 22 severe
  • 107 moderate
  • 27 minor
  • 427 info

Most severe, free to view

  • ClopidogrelB01AC04severe
  • NelfinavirJ05AE04severe
  • AtazanavirJ05AE08severe
  • RilpivirineJ05AG05severe

9 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rabeprazole in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rabeprazole products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Pariet, Rabeprazol 1a Pharma
  • Belgium · Pariet
  • Bulgaria · Ацилесол, Зулбекс
  • Cyprus · Pariet, Rabeprazole Krka
  • Czechia · Rapoxol, Zulbex
  • Germany · Pariet, Rabeprazol Puren
  • Denmark · Pariet, Rabeprazol Medical Valley
  • Estonia · Rabeprazole Actavis, Rabeprazole Doc Generici
  • Spain · Pariet, Rabeprazol Almus
  • Finland · Pariet, Rabeprazol Krka
  • United Kingdom (Northern Ireland) · Pariet, Rabeprazole Accord Healthcare
  • Greece · Aircodos, Berlex
  • Croatia · Ares, Zulbex
  • Hungary · Acilesol, Gelbra
  • Ireland · Pariet, Rabeprazole Krka
  • Iceland · Pariet, Rabeprazol Actavis
  • Italy · Akirab, Pariet
  • Lithuania · Rabeprazole Actavis, Yzilan
  • Luxembourg · Pariet
  • Latvia · Rabeprazole Adoh, Zulbex
  • Malta · Pariet
  • Netherlands · Beryx, Pariet
  • Poland · Zulbex
  • Portugal · Pariet, Rabeprazol Aurovitas
  • Romania · Relitaz, Zulbex
  • Sweden · Pariet
  • Slovenia · Rabeprazol Lek, Zulbex
  • Slovakia · Zulbex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ccc9f567-d8f9-4b77-900c-54ca55db8a8a
GET /v1/drugs/ccc9f567-d8f9-4b77-900c-54ca55db8a8a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66123498",
  "date_amm": "2012-03-16",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "RABÉPRAZOLE SODIQUE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé gastro-résistant(e)",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about rabeprazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.